Annual report pursuant to Section 13 and 15(d)

Income Taxes (Details)

v3.21.1
Income Taxes (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Income Tax Disclosure [Abstract]    
Net operating loss carryforward BiomX Inc. $ 719
Net operating loss carryforward BiomX Ltd. 14,473 5,953
Total deferred tax assets 15,192 5,953
Valuation allowance (15,192) (5,953)
Net deferred tax assets